BBOT vs BGM (BridgeBio Oncology Therapeutics Inc. vs BGM Group Ltd.)
Showing Closing Date Range from Oct 5 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
Today's Session Official Close
The regular trading session has completed and official closing prices are verified as of 7:56 PM ET. All metrics below represent finalized session performance.
BGM leads by +5.99% Alpha Spread Today
BBOT is trading at -2.78% while BGM is at +3.21% .
Started At
Official opening auction price
Closed At
Official exchange closing price
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | BBOT | BGM | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | -2.78% | +3.21% | BGM +5.99% |
| Net Dollar Move | $-0.10 | +$0.30 | BGM higher move |
| Open Price | $3.60 | $9.17 | Gap: 0.00% vs -1.93% |
| Day High | $3.72 | $9.80 | Session peaks |
| Day Low | $3.48 | $9.17 | Session troughs |
| Intraday Spread | $0.24 | $0.63 | High/Low spread |
| Share Volume | 659.6K | 7.6K | BBOT more active |
| Est. Dollar Volume | $2.31M | $72.9K | BBOT higher liquidity |
Explore BBOT vs BGM Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.